Skip Navigation
Skip to contents

Allergy Asthma Immunol Res.  2014 Mar;6(2):126-130. 10.4168/aair.2014.6.2.126.

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn

Affiliations
  • 1Department of Pediatrics, Dong-A University, College of Medicine, Busan, Korea.
  • 2Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea. neonate.kr@gmail.com

Abstract

PURPOSE
Transient tachypnea of the newborn (TTN) is a disorder caused by the delayed clearance of fetal alveolar fluid. beta-adrenergic agonists such as albuterol (salbutamol) are known to catalyze lung fluid absorption. This study examined whether inhalational salbutamol therapy could improve clinical symptoms in TTN. Additional endpoints included the diagnostic and therapeutic efficacy of salbutamol as well as its overall safety.
METHODS
From January 2010 through December 2010, we conducted a prospective study of 40 newborns hospitalized with TTN in the neonatal intensive care unit. Patients were given either inhalational salbutamol (28 patients) or placebo (12 patients), and clinical indices were compared.
RESULTS
The duration of tachypnea was shorter in patients receiving inhalational salbutamol therapy, although this difference was not statistically significant. The duration of supplemental oxygen therapy and the duration of empiric antibiotic treatment were significantly shorter in the salbutamol-treated group. No adverse effects were observed in either treatment group.
CONCLUSIONS
Inhalational salbutamol therapy reduced the duration of supplemental oxygen therapy and the duration of empiric antibiotic treatment, with no adverse effects. However, the time between salbutamol therapy and clinical improvement was too long to allow definitive conclusions to be drawn. Further studies examining a larger number of patients with strict control over dosage and frequency of salbutamol inhalations are necessary to better direct the treatment of TTN.

Keyword

Transient tachypnea of the newborn; inhalation; albuterol

MeSH Terms

Absorption
Adrenergic beta-Agonists
Albuterol*
Humans
Infant, Newborn
Inhalation
Intensive Care, Neonatal
Lung
Methods
Oxygen
Prospective Studies
Tachypnea
Transient Tachypnea of the Newborn*
Adrenergic beta-Agonists
Albuterol
Oxygen
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr